GPT and neuroblastoma: Interestingly, even though a significant fraction of ALT-positive NB tumors does not harbor ATRX mutations, such tumors often exhibit low ATRX protein expression, suggesting a recurrent pathway for ALT activation that involves ATRX loss of function [40, 82].